Stephan Gunther
Overview
Explore the profile of Stephan Gunther including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
262
Citations
15177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Penfold S, Adegnika A, Asogun D, Ayodeji O, Azuogu B, Fischer 2nd W, et al.
PLoS One
. 2025 Jan;
20(1):e0317720.
PMID: 39808605
[This corrects the article DOI: 10.1371/journal.pone.0283643.].
2.
Rojek A, Fieggen J, Paterson A, Byakika-Kibwika P, Camara M, Comer K, et al.
Lancet Infect Dis
. 2024 Dec;
25(3):e177-e188.
PMID: 39675367
A key lesson from the west Africa (2014-16) Ebola disease epidemic was that outbreak responses fail when they respond to patients through a narrow clinical lens without considering the broader...
3.
Semper A, Olver J, Warner J, Cehovin A, Fay P, Hart P, et al.
Lancet Infect Dis
. 2024 Nov;
PMID: 39522529
Crimean-Congo haemorrhagic fever (CCHF) is a widely distributed and potentially fatal tick-borne viral disease with no licensed specific treatments or vaccines. In 2019, WHO published an advanced draft of a...
4.
Watson C, Gsell P, Hall Y, Camacho A, Riveros X, Enwere G, et al.
BMC Med
. 2024 Nov;
22(1):523.
PMID: 39511527
Background: Zaire Ebolavirus disease (EVD) outbreaks can be controlled using rVSV-ZEBOV vaccination and other public health measures. People in high-risk areas may have pre-existing antibodies from asymptomatic Ebolavirus exposure that...
5.
Orth H, Pfau S, Gabriel M, Gunther S, Tappe D, Hornuss D, et al.
Euro Surveill
. 2024 Nov;
29(44).
PMID: 39484688
Mayaro virus is endemic to the tropical Americas, where the incidence is currently increasing. Like other viruses of the Semliki Forest virus serocomplex, such as , symptomatic infections are typically...
6.
Hoffmann C, Krasemann S, Wurr S, Hartmann K, Adam E, Bockholt S, et al.
Nat Commun
. 2024 Oct;
15(1):9319.
PMID: 39472431
Lassa virus (LASV) outbreaks in West Africa pose a significant public health threat. We investigated the infection phenotype and transmission (horizontal and vertical) of LASV strain Ba366 in its natural...
7.
Ogbaini-Emovon E, Akpede G, Okogbenin S, Osagiede E, Tobin E, Asogun D, et al.
Open Forum Infect Dis
. 2024 Oct;
11(10):ofae575.
PMID: 39450398
Background: The standard of care for Lassa fever is the use of ribavirin with supportive therapy. There is little information on the course of viremia and its relationship with clinical...
8.
Maier M, Neurohr E, Barreto-Miranda I, Gabriel M, Gunther S, Belard S
Infection
. 2024 Oct;
PMID: 39373950
No abstract available.
9.
Duvignaud A, Etafo I, Jaspard M, Salau Q, Serra B, Kareem A, et al.
J Pediatric Infect Dis Soc
. 2024 Aug;
13(10):513-522.
PMID: 39167706
Background: Data on the presentation, management, and outcomes of Lassa fever (LF) in children are limited. Methods: Description of the clinical and biological features, treatment, and outcomes of reverse transcriptase...
10.
Moore K, Ostrowsky J, Mehr A, Johnson R, Ulrich A, Moua N, et al.
Lancet Infect Dis
. 2024 Jul;
24(11):e696-e706.
PMID: 38964363
In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part of the WHO Blueprint for Action to Prevent Epidemics. One aspect of preparedness is to promote...